Allex

Allex

toxin type BLtdcancer-3 presentations-187 days--B-Tenecteplase -tenecteplase -A--UKBoehringer Ingelheim International GmbH--B01AD Treatment of suspected myocardial infarction---Powder and solvent for solution for injection 6000 IU, 8000 IU, 10000 IU 3 presentations-229 days-24.09.1999 -21.09.2000 -176 days -215 days--27.11.2000 ----D-Metalyse -tenecteplase -A-Boehringer Ingelheim International GmbH--B01AD Treatment of suspected myocardial infarction---Powder and solvent for solution for injection 6000 IU, 8000 IU, 10000 IU 3 presentations-24.09.1999 -21.09.2000 -176 days -215 days-27.11.2000 ----D-Azomyr -desloratadine -B-Opulis -desloratadine -B-Allex -desloratadine -B-Aerius -desloratadine -B-Neoclarityn -desloratadine -B-Xeloda -capecitabine -B-SP Europe -US-SP Europe -US-SP Europe -US-SP Europe -US-SP Europe -US-Roche Registration Ltd -CH------------R06AX27 Relief of symptoms associated with seasonal allergic rhinitis R06AX27 Relief of symptoms associated with seasonal allergic rhinitisR06AX27 Relief of symptoms associated with seasonal allergic rhinitisR06AX27 Relief of symptoms associated with seasonal allergic rhinitisR06AX27 Relief of symptoms associated with seasonal allergic rhinitis L01BC treatment of metastatic colorectal cancer-Film coated tablet -5 mg -13 presentations-Film coated tablet -5 mg -13 presentations-Film coated tablet -5 mg -13 presentations-Film coated tablet -5 mg -13 presentations-Film coated tablet -5 mg -13 presentations-Film coated tablet -150 mg, 500 mg -2 presentations-24.09.1999 -21.09.2000 -201 days -159 days -24.09.1999 -21.09.2000 -201 days -159 days-24.09.1999 -21.09.2000 -201 days -159 days-24.09.1999 -21.09.2000 -201 days -159 days-24.09.1999 -21.09.2000 -201 days -159 days -21.10.1999 -21.09.2000 -201 days -159 days

00 Part A (QJ57DA) -176 days -OJ C 95, 04.04.2000 Metacam Boehringer Dogs Solution for injection -12.01.1999 -10.12.1999 Meloxicam Ingelheim Initiation therapy 5 mg/ml -10.11.1999 -24.03.2000 Part B D for alleviation of 1 -210 days -27.03.2000 extension pain and -92 days -OJ C 120, inflammation 28.04.2000 (QM01AC06) Incurin Intervet Dogs Scored tablets -14.07.1998 -07.01.2000 Oestriol Internation Hormone-1 mg -08.12.1999 -24.03.2000 Part B al dependent urinary 1 -210 days -29.03.2000 NL incontinence -302 days -OJ C 120, (QG03CA04) 28.04.2000 Rabigen Virbac Foxes Liquid within a blister -23.03.1998 -07.01.2000 SAG2 F Vaccine against pack embedded in a bait -08.12.1999 -06.04.2000 Live vaccine rabies 8 log 10 CCID50 -196 days -10.04.2000 Part A (QJ57HA) 2 -428 days -OJ C 120, 28.04.2000 Eurifel FeLV Merial Cats Pellet plus diluent -12.01.1999 -07.01.2000 Live vaccine F Vaccine against 1 ml -08.12.1999 -13.04.2000 Part A feline leukaemis 3 -183 days -18.04.2000 (QJ57BA04) -120 days -OJ C 120, 28.04.2000 Porcilis Pesti Intervet Pigs Water in oil emulsion -14.07.1998 -12.11.1999 Inactivated Internation Marker vaccine 120 Elisa Units/2ml -13.10.1999 -09.06.2000 vaccine al against CSF 3 -210 days -14.06.2000 Part A NL (QJ57EA) -246 days -OJ C 183, 30.06.2000 Ibaflin Intervet Dogs Tablet -12.01.1999 -10.03.2000 Ibafloxacin Internation Pyoderma 150 300mg -09.02.2000 -13.06.2000 Part B al (QG51AC) 1 -210 days -15.06.2000 NL -184 days -OJ C 183, 30.06.2000 Metacam Boehringer Dogs Solution for injection -02.01.2000 -28.04.2000 Meloxicam Ingelheim Post-operative pain 5mg/ml -19.04.2000 -15.09.2000 Part B D (QM01AC06) 1 -101 days -18.09.2000 (extension) -7 days -OJ C 277, 29.09.2000 Econor Novartis Pigs 0.5% premix -10.08.1999 -19.05.2000 Valnemulin A Prevention various -19.04.2000 -15.09.2000 Part B treatment of 2 -210 days -20.09.2000 (extension) dysentery -43 days -OJ C 308, (QJ01XX94) 27.10.2000 Econor Novartis Pigs 10%/50% premix -12.10.1999 -07.04.2000 Valnemulin A Prevention various -08.03.2000 -15.09.2000 Part B/treatment of 2 -148 days -20.09.2000 extension dysentery and -0 -OJ No.308, treatment/control of 27.10.2000 enzootic pneumonia (QJ01XX94) EMEA/MB/050/00 Relazione annuale 2000 Pagina 80/91 Prodotto Ditta Area terapeutica Presentazione EMEA/CVMP Commissione -Nome -Nome -Specie bersaglio -Forma -Convalida -Parere ricevuto il commerciale -DCI -Origine -Indicazione -Dosaggio -Parere -Data della decisione -Parte A/B -Numero di presentazioni -Tempo attivo -Data delle notifica -Tempo inattivo -Rif.